{"id":31,"date":"2024-06-28T07:06:43","date_gmt":"2024-06-28T05:06:43","guid":{"rendered":"https:\/\/www.ipsen.com\/canada\/?page_id=31"},"modified":"2025-07-01T10:02:32","modified_gmt":"2025-07-01T08:02:32","slug":"press-releases","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/canada\/press-releases\/","title":{"rendered":"Press Releases"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img\" style=\"background-image:url(https:\/\/www.ipsen.com\/canada\/wp-content\/uploads\/sites\/16\/2025\/07\/Newsroom-Press-Releases.jpg)\">\n        <div class=\"container content-sec\">\n            <nav aria-label=\"breadcrumb\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/www.ipsen.com\/canada\">Home<\/a><\/li><li class=\"breadcrumb-item active\"><a class=\"link-pointer-events-none\" href=\"#\" aria-current=\"page\">Press Releases<\/a><\/li><\/ol>\n            <\/nav>            <h1 class=\"visible\">Press Releases<\/h1>\n            <p class=\"visible\">A comprehensive library of Ipsen media releases for investors and members of the press.<\/p>\n        <\/div>\n    <\/section>\n\n\n\n<section class=\"media-filter\">\n    <div class=\"container media-filter-inner\">\n                        <h3 class=\"media-filter-title charcoal-grey heading-three\" role=\"heading\" aria-level=\"2\">\n                    Explore more press releases                <\/h3>\n                <div class=\"media-filter-main\" id=\"search-total-div\" data-langaugecode=\"en\" data-paginationtype=\"visible\" data-loadmore=\"hidden\" data-filtertype=\"pressrelease\" data-posttype=\"press_release\"\n            data-pagination=\"visible\" data-parenttermid=\"[28,30,32,33]\">\n            <div class=\"row\">\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                                        <!-- media drop down -->\n                    <div class=\"media-drop-down\">\n                        <button class=\"media-drop-heading\">Filter<\/button>\n                        <div class=\"media-dropdown-items\">\n                            <div class=\"row\">\n                                                            <div class=\"column-1 col-lg-4 col-md-4 col-sm-12\">\n                                    <div class=\"topic-filter\">\n                                                                                <p id=\"topic-filter-accessibility\">Topics<\/p>\n                                                                                <div class=\"mutltiselect-dropdown topic-cat-dropdown\">\n                                            <select name=\"langOpt[]\" multiple id=\"topicOpt\">\n                                                                                                <option value=\"28\">Corporate                                                <\/option>\n                                                                                                <option value=\"30\">Neuroscience                                                <\/option>\n                                                                                                <option value=\"32\">Oncology                                                <\/option>\n                                                                                                <option value=\"33\">Rare Diseases                                                <\/option>\n                                                                                            <\/select>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                                                                                                                                <div class=\"column-2 col-lg-4 col-md-4 col-sm-12\">\n                                    <div class=\"period-filter\">\n                                            <p id=\"period-filter-accessibility\">Period<\/p>\n                                          <div class=\"mutltiselect-dropdown year-dropdown\">\n                                            <select name=\"langOpt[]\" multiple id=\"periodOpt\">\n                                                                                            <option value=\"2026\">2026                                                                                            <option value=\"2025\">2025                                                                                            <option value=\"2024\">2024                                                                                            <option value=\"2023\">2023                                                                                            <option value=\"2022\">2022                                                                                            <option value=\"2021\">2021                                                                                            <option value=\"2020\">2020                                                                                            <option value=\"2019\">2019                                                                                            <option value=\"2018\">2018                                                                                            <option value=\"2017\">2017                                                                                        <\/select>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                                \n                                                                                                            <div class=\"column-3 col-lg-4 col-md-4 \">\n                                            <div class=\"filterby-filter\">\n                                            <label for=\"filter-by\">Filter by<\/label>\n                                                <div class=\"input-filter\">\n                                                    <input type=\"search\" name=\"filter-by\" id=\"filter-by\"\n                                                        placeholder=\"Type a keyword\" >\n                                                        <button class=\"filter-clear-icon\" id=\"filterClearSearch\">X<\/button>\n                                                <\/div>\n                                                <div class=\"filter-by-dropdown\">\n                                                    <p class=\"recent\">recent search<\/p>\n                                                                                                        <ul class=\"filter-by-list\">\n                                                                                                            <\/ul>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                                                                                                              <\/div>\n                            <div class=\"reset-btn-div\">\n                                <a href=\"#\" class=\"reset-btn\">Reset<\/a>\n                            <\/div>\n                        <\/div>\n                    <\/div>\n                                        <!-- sorting section -->\n                                            <section class=\"media-filter\">\n                            <div class=\"container media-filter-inner\">\n                                <div class=\"media-filter-main\" id=\"search-total-div\" data-langaugecode=\"en\" data-paginationtype=\"visible\" data-loadmore=\"hidden\" data-filtertype=\"investor-event\" data-posttype=\"event\" data-pagination=\"visible\" data-parenttermid=\"[492,493,1810,494]\">\n                                    <div class=\"row\">\n                                        <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                                        <div class=\"sorting-sec\">\n                                                                                    <div class=\"row\">\n                                                                                                    <div class=\"column-1 col-xl-6 col-lg-6 col-sm-12\">\n                                                        <div class=\"no-of-item-sec\">\n                                                            <p>Showing: <span id=\"start-value\">1<\/span> &#8211; <span id=\"no-of-search\">05<\/span> of <span id=\"total-count\">20<\/span>\n                                                                <\/p>\n                                                        <\/div>\n                                                    <\/div>\n                                                                                                <div class=\"column-2 col-xl-6 col-lg-6 col-sm-12\">\n                                                                                                            <div class=\"sort-input\">\n                                                            <div class=\"sort-input-inner\">\n                                                            <label for=\"sorting-input\">Show<\/label>\n                                                                                                                            <select name=\"order\" aria-label=\"show list\" id=\"show-list\" tabindex=\"0\">\n                                                                    <option value=\"05\" selected>05<\/option>\n                                                                    <option value=\"10\" >10<\/option>\n                                                                    <option value=\"20\" >20<\/option>\n                                                                    <option value=\"30\" >30<\/option>\n                                                                    <option value=\"40\" >40<\/option>\n                                                                    <option value=\"50\" >50<\/option>\n                                                                <\/select>\n                                                            <\/div>\n                                                        <\/div>\n                                                \n                                                                                                                                                                <div class=\"sort-input-ascending\">\n                                                            <div class=\"sort-input-ascending-inner\">\n                                                                <label for=\"sorting-input-ascend\">Sort<\/label>\n                                                                <select name=\"sorting-input-ascend\" id=\"show-list-as\" class=\"show-list-as\" tabindex=\"0\" aria-label=\"sorting\">\n                                                                    <option value=\"DESC\" aria-label=\"Descending\" selected>Descending<\/option>\n                                                                    <option value=\"ASC\" aria-label=\"Ascending\"  >Ascending<\/option>                                                    \n                                                                <\/select>\n                                                            <\/div>\n                                                        <\/div>                                        \n                                                    \t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n                                                <\/div>\n                                            <\/div>\n                                                                                       \n                                        <\/div>\n                                        <\/div>\n                                    <\/div>\n                                <\/div>\n                            <\/div>\n                        \n                        <\/section>\n                                        <!-- Search listing include start here-->\n                    <div id=\"search-results\" class=\"story-div\">\n                        <!-- Press Release Listing start here -->\n<div class=\"story-div\" id=\"search-div\">\n\t<div>\n<div class=\"row story-row pr-card\">\n            <div class=\"column-1 col-lg-12 col-md-12 col-sm-12\">\n            <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                                        <span class=\"desk-span\">\n                        <span class=\"story-date\">28 April 2025                            <!-- <span class=\"story-read-time\">6 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">28 April 2025<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                                    <div class=\"story-share-sec visible\">\n                        <div class=\"share\"  data-title=\" Health Canada approves IQIRVO\u00ae as a first-in-class dual-peroxisome proliferator-activated receptor treatment for primary biliary cholangitis\">\n                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/share-icon.svg\"\n                                alt=\"Share On Social Media\" title=\"Share On Social Media\"\/>\n                        <\/div>\n                        <div class=\"share-tray hidden\">\n                                                        <a href=\"https:\/\/www.linkedin.com\/shareArticle?url=https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-iqirvo-as-a-first-in-class-dual-peroxisome-proliferator-activated-receptor-treatment-for-primary-biliary-cholangitis\/&#038;title=Health Canada approves IQIRVO\u00ae as a first-in-class dual-peroxisome proliferator-activated receptor treatment for primary biliary cholangitis&#038;media=https:\/\/www.ipsen.com\/canada\/wp-content\/uploads\/sites\/16\/2024\/08\/PressRelease_EN.jpg\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/LinkedIn.svg\" alt=\"Share on LinkedIn\" title=\"Share on LinkedIn\"\/>LinkedIn\n                            <\/a>\n                                                       <!-- <a href=\"\">\n                                <img decoding=\"async\" src=\"\" alt=\"\" title=\"\"\/>Twitter\n                            <\/a> -->\n                                                        <a href=\"https:\/\/www.facebook.com\/sharer.php?u=https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-iqirvo-as-a-first-in-class-dual-peroxisome-proliferator-activated-receptor-treatment-for-primary-biliary-cholangitis\/&#038;p=Health Canada approves IQIRVO\u00ae as a first-in-class dual-peroxisome proliferator-activated receptor treatment for primary biliary cholangitis\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/Facebook.png\" alt=\"Share on Facebook\" title=\"Share on Facebook\" \/>Facebook\n                            <\/a>\n                                                    <\/div>\n                    <\/div>\n                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-iqirvo-as-a-first-in-class-dual-peroxisome-proliferator-activated-receptor-treatment-for-primary-biliary-cholangitis\/\">\n                        <h5 class=\"blue-txt\" role=\"heading\" aria-level=\"3\">Health Canada approves IQIRVO\u00ae as a first-in-class dual-peroxisome proliferator-activated receptor treatment for primary biliary cholangitis<\/h5>\n                    <\/a>\n                                <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n            <div class=\"column-1 col-lg-12 col-md-12 col-sm-12\">\n            <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                                        <span class=\"desk-span\">\n                        <span class=\"story-date\">04 May 2022                            <!-- <span class=\"story-read-time\">4 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">04 May 2022<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                                    <div class=\"story-share-sec visible\">\n                        <div class=\"share\"  data-title=\" Health Canada approves Ipsen\u2019s CABOMETYX\u00ae (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory or Ineligible Differentiated Thyroid Cancer\">\n                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/share-icon.svg\"\n                                alt=\"Share On Social Media\" title=\"Share On Social Media\"\/>\n                        <\/div>\n                        <div class=\"share-tray hidden\">\n                                                        <a href=\"https:\/\/www.linkedin.com\/shareArticle?url=https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-ipsens-cabometyx-cabozantinib-for-patients-with-previously-treated-radioactive-iodine-refractory-or-ineligible-differentiated-thyroid-cancer\/&#038;title=Health Canada approves Ipsen\u2019s CABOMETYX\u00ae (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory or Ineligible Differentiated Thyroid Cancer&#038;media=\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/LinkedIn.svg\" alt=\"Share on LinkedIn\" title=\"Share on LinkedIn\"\/>LinkedIn\n                            <\/a>\n                                                       <!-- <a href=\"\">\n                                <img decoding=\"async\" src=\"\" alt=\"\" title=\"\"\/>Twitter\n                            <\/a> -->\n                                                        <a href=\"https:\/\/www.facebook.com\/sharer.php?u=https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-ipsens-cabometyx-cabozantinib-for-patients-with-previously-treated-radioactive-iodine-refractory-or-ineligible-differentiated-thyroid-cancer\/&#038;p=Health Canada approves Ipsen\u2019s CABOMETYX\u00ae (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory or Ineligible Differentiated Thyroid Cancer\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/Facebook.png\" alt=\"Share on Facebook\" title=\"Share on Facebook\" \/>Facebook\n                            <\/a>\n                                                    <\/div>\n                    <\/div>\n                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-ipsens-cabometyx-cabozantinib-for-patients-with-previously-treated-radioactive-iodine-refractory-or-ineligible-differentiated-thyroid-cancer\/\">\n                        <h5 class=\"blue-txt\" role=\"heading\" aria-level=\"3\">Health Canada approves Ipsen\u2019s CABOMETYX\u00ae (cabozantinib) for Patients with Previously Treated Radioactive Iodine-Refractory or Ineligible Differentiated Thyroid Cancer<\/h5>\n                    <\/a>\n                                <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n            <div class=\"column-1 col-lg-12 col-md-12 col-sm-12\">\n            <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                                        <span class=\"desk-span\">\n                        <span class=\"story-date\">20 October 2021                            <!-- <span class=\"story-read-time\">4 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">20 October 2021<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                                    <div class=\"story-share-sec visible\">\n                        <div class=\"share\"  data-title=\" Health Canada approves Ipsen\u2019s CABOMETYX\u00ae (cabozantinib) in combination with OPDIVO\u00ae (nivolumab) as a first-line treatment for adults with advanced or metastatic renal cell carcinoma\">\n                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/share-icon.svg\"\n                                alt=\"Share On Social Media\" title=\"Share On Social Media\"\/>\n                        <\/div>\n                        <div class=\"share-tray hidden\">\n                                                        <a href=\"https:\/\/www.linkedin.com\/shareArticle?url=https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-ipsens-cabometyx-cabozantinib-in-combination-with-opdivo-nivolumab-as-a-first-line-treatment-for-adults-with-advanced-or-metastatic-renal-cell-carcinoma\/&#038;title=Health Canada approves Ipsen\u2019s CABOMETYX\u00ae (cabozantinib) in combination with OPDIVO\u00ae (nivolumab) as a first-line treatment for adults with advanced or metastatic renal cell carcinoma&#038;media=\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/LinkedIn.svg\" alt=\"Share on LinkedIn\" title=\"Share on LinkedIn\"\/>LinkedIn\n                            <\/a>\n                                                       <!-- <a href=\"\">\n                                <img decoding=\"async\" src=\"\" alt=\"\" title=\"\"\/>Twitter\n                            <\/a> -->\n                                                        <a href=\"https:\/\/www.facebook.com\/sharer.php?u=https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-ipsens-cabometyx-cabozantinib-in-combination-with-opdivo-nivolumab-as-a-first-line-treatment-for-adults-with-advanced-or-metastatic-renal-cell-carcinoma\/&#038;p=Health Canada approves Ipsen\u2019s CABOMETYX\u00ae (cabozantinib) in combination with OPDIVO\u00ae (nivolumab) as a first-line treatment for adults with advanced or metastatic renal cell carcinoma\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/Facebook.png\" alt=\"Share on Facebook\" title=\"Share on Facebook\" \/>Facebook\n                            <\/a>\n                                                    <\/div>\n                    <\/div>\n                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-ipsens-cabometyx-cabozantinib-in-combination-with-opdivo-nivolumab-as-a-first-line-treatment-for-adults-with-advanced-or-metastatic-renal-cell-carcinoma\/\">\n                        <h5 class=\"blue-txt\" role=\"heading\" aria-level=\"3\">Health Canada approves Ipsen\u2019s CABOMETYX\u00ae (cabozantinib) in combination with OPDIVO\u00ae (nivolumab) as a first-line treatment for adults with advanced or metastatic renal cell carcinoma<\/h5>\n                    <\/a>\n                                <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n            <div class=\"column-1 col-lg-12 col-md-12 col-sm-12\">\n            <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                                        <span class=\"desk-span\">\n                        <span class=\"story-date\">16 March 2021                            <!-- <span class=\"story-read-time\">7 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">16 March 2021<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                                    <div class=\"story-share-sec visible\">\n                        <div class=\"share\"  data-title=\" Health Canada Approves INCRELEX\u00ae, First and Only Recombinant Human Insulin-like Growth Factor-1 (IGF-1) Therapy in Canada for the Treatment of Severe Growth Failure Associated with Ultra-Rare Condition in Children and Adolescents\">\n                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/share-icon.svg\"\n                                alt=\"Share On Social Media\" title=\"Share On Social Media\"\/>\n                        <\/div>\n                        <div class=\"share-tray hidden\">\n                                                        <a href=\"https:\/\/www.linkedin.com\/shareArticle?url=https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-increlex-first-and-only-recombinant-human-insulin-like-growth-factor-1-igf-1-therapy-in-canada-for-the-treatment-of-severe-growth-failure-associated-with-ultra-rare-con\/&#038;title=Health Canada Approves INCRELEX\u00ae, First and Only Recombinant Human Insulin-like Growth Factor-1 (IGF-1) Therapy in Canada for the Treatment of Severe Growth Failure Associated with Ultra-Rare Condition in Children and Adolescents&#038;media=\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/LinkedIn.svg\" alt=\"Share on LinkedIn\" title=\"Share on LinkedIn\"\/>LinkedIn\n                            <\/a>\n                                                       <!-- <a href=\"\">\n                                <img decoding=\"async\" src=\"\" alt=\"\" title=\"\"\/>Twitter\n                            <\/a> -->\n                                                        <a href=\"https:\/\/www.facebook.com\/sharer.php?u=https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-increlex-first-and-only-recombinant-human-insulin-like-growth-factor-1-igf-1-therapy-in-canada-for-the-treatment-of-severe-growth-failure-associated-with-ultra-rare-con\/&#038;p=Health Canada Approves INCRELEX\u00ae, First and Only Recombinant Human Insulin-like Growth Factor-1 (IGF-1) Therapy in Canada for the Treatment of Severe Growth Failure Associated with Ultra-Rare Condition in Children and Adolescents\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/Facebook.png\" alt=\"Share on Facebook\" title=\"Share on Facebook\" \/>Facebook\n                            <\/a>\n                                                    <\/div>\n                    <\/div>\n                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/canada\/press-releases\/health-canada-approves-increlex-first-and-only-recombinant-human-insulin-like-growth-factor-1-igf-1-therapy-in-canada-for-the-treatment-of-severe-growth-failure-associated-with-ultra-rare-con\/\">\n                        <h5 class=\"blue-txt\" role=\"heading\" aria-level=\"3\">Health Canada Approves INCRELEX\u00ae, First and Only Recombinant Human Insulin-like Growth Factor-1 (IGF-1) Therapy in Canada for the Treatment of Severe Growth Failure Associated with Ultra-Rare Condition in Children and Adolescents<\/h5>\n                    <\/a>\n                                <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<div>\n<div class=\"row story-row pr-card\">\n            <div class=\"column-1 col-lg-12 col-md-12 col-sm-12\">\n            <div class=\"story-post\">\n            <div class=\"story-time-div\">\n                <div class=\"story-info-sec\">\n                                        <span class=\"desk-span\">\n                        <span class=\"story-date\">04 May 2020                            <!-- <span class=\"story-read-time\">6 mins read<\/span> -->\n                        <\/span>\n                        <p class=\"mob-span\">\n                            <span class=\"story-date\">04 May 2020<\/span>\n                            <!-- <span class=\"story-read-time\"><\/span> -->\n                        <\/p>\n                <\/div>\n                                                    <div class=\"story-share-sec visible\">\n                        <div class=\"share\"  data-title=\" Ipsen enters into an option agreement with IRICoR and Universit\u00e9 de Montr\u00e9al for a discovery-stage oncology program\">\n                            <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/share-icon.svg\"\n                                alt=\"Share On Social Media\" title=\"Share On Social Media\"\/>\n                        <\/div>\n                        <div class=\"share-tray hidden\">\n                                                        <a href=\"https:\/\/www.linkedin.com\/shareArticle?url=https:\/\/www.ipsen.com\/canada\/press-releases\/ipsen-enters-into-an-option-agreement-with-iricor-and-universite-de-montreal-for-a-discovery-stage-oncology-program\/&#038;title=Ipsen enters into an option agreement with IRICoR and Universit\u00e9 de Montr\u00e9al for a discovery-stage oncology program&#038;media=\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/LinkedIn.svg\" alt=\"Share on LinkedIn\" title=\"Share on LinkedIn\"\/>LinkedIn\n                            <\/a>\n                                                       <!-- <a href=\"\">\n                                <img decoding=\"async\" src=\"\" alt=\"\" title=\"\"\/>Twitter\n                            <\/a> -->\n                                                        <a href=\"https:\/\/www.facebook.com\/sharer.php?u=https:\/\/www.ipsen.com\/canada\/press-releases\/ipsen-enters-into-an-option-agreement-with-iricor-and-universite-de-montreal-for-a-discovery-stage-oncology-program\/&#038;p=Ipsen enters into an option agreement with IRICoR and Universit\u00e9 de Montr\u00e9al for a discovery-stage oncology program\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/canada\/wp-content\/themes\/ipsen-main\/dist\/images\/Facebook.png\" alt=\"Share on Facebook\" title=\"Share on Facebook\" \/>Facebook\n                            <\/a>\n                                                    <\/div>\n                    <\/div>\n                            <\/div>\n            <div class=\"story-post-content\">\n                    <a href=\"https:\/\/www.ipsen.com\/canada\/press-releases\/ipsen-enters-into-an-option-agreement-with-iricor-and-universite-de-montreal-for-a-discovery-stage-oncology-program\/\">\n                        <h5 class=\"blue-txt\" role=\"heading\" aria-level=\"3\">Ipsen enters into an option agreement with IRICoR and Universit\u00e9 de Montr\u00e9al for a discovery-stage oncology program<\/h5>\n                    <\/a>\n                                <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\t\t\n<\/div>\n<br>\n\t\t\t<nav class=\"pagination\" aria-label=\"Pagination\"><ul><li><span class='page-numbers current' aria-current='page' aria-hidden='true' aria-label='Page 1 (current)'>1<\/span><\/li><li><a class='page-numbers' aria-hidden='false' tabindex='0' aria-label='Page 2' onkeydown='if(event.key===\"Enter\"||event.key===\"\"||event.code===\"Space\"){paginationClick(2)}' onclick='paginationClick(2)'>2<\/a><\/li><li><span class='page-numbers dots' aria-hidden='true' tabindex='-1'>&#8230;<\/span><\/li><li><a class='page-numbers' aria-hidden='false' tabindex='0' aria-label='Page 4' onkeydown='if(event.key===\"Enter\"||event.key===\"\"||event.code===\"Space\"){paginationClick(4)}' onclick='paginationClick(4)'>4<\/a><\/li><li><a aria-label='Next Page' class='next page-numbers' aria-hidden='false' tabindex='0' onkeydown='if(event.key===\"Enter\"||event.key===\"\"||event.code===\"Space\"){paginationClick(2)}' onclick='paginationClick(2)'><\/a><\/li><\/ul><\/nav><\/div>\n<!-- Press Release Listing Ends here -->\n                        <!-- Search listing include end here-->\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-31","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Ipsen media releases<\/title>\n<meta name=\"description\" content=\"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/canada\/press-releases\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ipsen media releases\" \/>\n<meta property=\"og:description\" content=\"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/canada\/press-releases\/\" \/>\n<meta property=\"og:site_name\" content=\"Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-01T08:02:32+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/canada\/press-releases\/\",\"url\":\"https:\/\/www.ipsen.com\/canada\/press-releases\/\",\"name\":\"Ipsen media releases\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/canada\/#website\"},\"datePublished\":\"2024-06-28T05:06:43+00:00\",\"dateModified\":\"2025-07-01T08:02:32+00:00\",\"description\":\"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/canada\/press-releases\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/canada\/press-releases\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/canada\/press-releases\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/canada\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press Releases\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/canada\/#website\",\"url\":\"https:\/\/www.ipsen.com\/canada\/\",\"name\":\"Canada\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/canada\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/canada\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/canada\/#organization\",\"name\":\"Canada\",\"url\":\"https:\/\/www.ipsen.com\/canada\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/canada\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/canada\/wp-content\/uploads\/sites\/16\/2024\/06\/Logo-Ipsen-new.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/canada\/wp-content\/uploads\/sites\/16\/2024\/06\/Logo-Ipsen-new.svg\",\"caption\":\"Canada\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/canada\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ipsen media releases","description":"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/canada\/press-releases\/","og_locale":"en_US","og_type":"article","og_title":"Ipsen media releases","og_description":"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.","og_url":"https:\/\/www.ipsen.com\/canada\/press-releases\/","og_site_name":"Canada","article_modified_time":"2025-07-01T08:02:32+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/canada\/press-releases\/","url":"https:\/\/www.ipsen.com\/canada\/press-releases\/","name":"Ipsen media releases","isPartOf":{"@id":"https:\/\/www.ipsen.com\/canada\/#website"},"datePublished":"2024-06-28T05:06:43+00:00","dateModified":"2025-07-01T08:02:32+00:00","description":"A comprehensive feed of Ipsen media releases intended for investors and members of the press, plus contact details for press liaison.","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/canada\/press-releases\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/canada\/press-releases\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/canada\/press-releases\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/canada\/"},{"@type":"ListItem","position":2,"name":"Press Releases"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/canada\/#website","url":"https:\/\/www.ipsen.com\/canada\/","name":"Canada","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/canada\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/canada\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/canada\/#organization","name":"Canada","url":"https:\/\/www.ipsen.com\/canada\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/canada\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/canada\/wp-content\/uploads\/sites\/16\/2024\/06\/Logo-Ipsen-new.svg","contentUrl":"https:\/\/www.ipsen.com\/canada\/wp-content\/uploads\/sites\/16\/2024\/06\/Logo-Ipsen-new.svg","caption":"Canada"},"image":{"@id":"https:\/\/www.ipsen.com\/canada\/#\/schema\/logo\/image\/"}}]}},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/ipsen.com\/canada\/press-releases\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"WebPage","headline":"Press Releases","url":"http:\/\/www.ipsen.com\/canada\/press-releases\/","mainEntityOfPage":{"@type":"WebPage","@id":"http:\/\/www.ipsen.com\/canada\/press-releases\/"},"thumbnailUrl":"","image":{"@type":"ImageObject","url":""},"articleSection":"Uncategorized","author":[{"@type":"Person","name":"navya"}],"creator":["navya"],"publisher":{"@type":"Organization","name":"Canada","logo":""},"keywords":[],"dateCreated":"2024-06-28T05:06:43Z","datePublished":"2024-06-28T05:06:43Z","dateModified":"2025-07-01T08:02:32Z"},"rendered":"<script type=\"application\/ld+json\" class=\"wp-parsely-metadata\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"WebPage\",\"headline\":\"Press Releases\",\"url\":\"http:\\\/\\\/www.ipsen.com\\\/canada\\\/press-releases\\\/\",\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.ipsen.com\\\/canada\\\/press-releases\\\/\"},\"thumbnailUrl\":\"\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"\"},\"articleSection\":\"Uncategorized\",\"author\":[{\"@type\":\"Person\",\"name\":\"navya\"}],\"creator\":[\"navya\"],\"publisher\":{\"@type\":\"Organization\",\"name\":\"Canada\",\"logo\":\"\"},\"keywords\":[],\"dateCreated\":\"2024-06-28T05:06:43Z\",\"datePublished\":\"2024-06-28T05:06:43Z\",\"dateModified\":\"2025-07-01T08:02:32Z\"}<\/script>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/ipsen.com\/p.js"},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/canada\/wp-json\/wp\/v2\/pages\/31","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/canada\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/canada\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/canada\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/canada\/wp-json\/wp\/v2\/comments?post=31"}],"version-history":[{"count":5,"href":"https:\/\/www.ipsen.com\/canada\/wp-json\/wp\/v2\/pages\/31\/revisions"}],"predecessor-version":[{"id":1826,"href":"https:\/\/www.ipsen.com\/canada\/wp-json\/wp\/v2\/pages\/31\/revisions\/1826"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/canada\/wp-json\/wp\/v2\/media?parent=31"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}